Your Partner in Advancing Science, ADN CoE
Prof. Dr. Teoman Kilic
Kocaeli University Hospital
Teoman Kilic (Professor, MD) was graduated from Ege University Faculty of Medicine in 1998. He completed his specialty in cardiology at Kocaeli University Faculty of Medicine. In 2006; he participated in the observer- ship project of Partners International Program of Harvard University and studied in the cardiac catheterization laboratories of Brigham and Women’s hospital and Massachusetts General Hospital. During this period, he participated in the “Impact of time of presentation on the care and outcomes of acute myocardial infarction” project of AHA Get with the Guidelines Steering Committee and investigators. In 2011; he participated in the observership and training programme of percutenous interventions on structural heart disease and studied in the cardiac catheterization laboratory of Cardiovascular center, Skt Katharinan Hospital, Frankfurt, Germany and in the cardiac catheterization laboratory of Johannes Guetenberg university, Mainz, Germany. Since 2013, he has been the Director of Structural Heart Interventions in the Catheterization Laboratory at the Kocaeli University, one of the busiest and most important reference centers of Turkey for structural heart interventions such as, left atrial appandage closure, paravalvular leak closure and transcatheter aortic valve implantations in Turkey. He has trained and/or proctored several doctors in Turkey, Kazakhstan, Dubai and Azerbaijan, mainly on the use of occlusion devices, mitral balloon valvuloplasty and transcatheter aortic valve implantation. His major area of interest is in the development of techniques and catheters/devices to help treat or cure adult congenital and structural cardiac diseases without open-heart surgery. He has published over 40 papers in Turkish Medical Journals and over 40 papers in International Journals. In 2018, he published an article describing a “New Pulmonary Valvuloplasty Technique by Use of an Hourglass-Shaped Balloon in adult patients with pulmonary stenosis”. He also published two important articles about antegrade and retrograde closure of mitral paravalvular leaks without creating of an arteriovenous wire loop. Dr Kilic performed the first LAMPOON procedure in Turkey, first “tip-to-base” LAMPOON procedure outside the US and first LAMPOON case before transcatheter Myval™ replacement in mitral position. He has been the national coordinator of the AFR Prophet Study in Turkey and one of the coordinator centers of AFR Prelieve study and one of the main centers of European Paravalvular Leak Closure study. He is the member of Turkish Society of Cardiology, European Society of Cardiology (ESC), Working Group on European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and American Heart Association . In the last 6 years, he has participated in the all organizations of Turkish Society of Interventional Cardiology meetings in Turkey and at the moment, he is the next president (President-elect) of Turkish Society of Cardiology Association of Percutaenous Cardiovascular Interventions (TSC-TAPCI).
Complex Atrial Septal Defect Closure Training
The training program for cardiologists focuses on atrial septal defect closure, led by a renowned instructor. Participants learn advanced techniques through lectures, discussions, and live case observations. The program includes hands-on experience in a cath lab, allowing participants to apply the techniques learned.
7/17/23
Starts At
Ends At
7/18/23
LAA CLOSURE Training
The LAA Closure training program is designed to equip cardiologists with the knowledge, skills, and techniques to excel in interventional cardiology. It is tailored to cardiologists' needs and offers a seamless learning experience. The program covers topics such as patient selection, device selection, procedural techniques, and potential complications. Participants will observe live LAA closure cases and gain practical experience in deploying devices. The training session includes introductions, introductions, and discussions on LAA closure, preventing stroke, current indications, and complications.
7/3/23
Starts At
Ends At
7/4/23